# Cellular Reprogramming-Enhanced Skin Grafting for Diabetic Foot Ulcers

> **NCT02070835** · NA · COMPLETED · sponsor: **Hu Zhicheng** · enrollment: 108 (actual)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **DEVICE:** autologous skin cell
- **PROCEDURE:** skin graft

## Key facts

- **NCT ID:** NCT02070835
- **Lead sponsor:** Hu Zhicheng
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-01
- **Primary completion:** 2023-12-30
- **Final completion:** 2023-12-30
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2026-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02070835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02070835, "Cellular Reprogramming-Enhanced Skin Grafting for Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02070835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*